Log in | Register

Home
All Journals
Biologics: Targets and Therapy
List of Issues
Volume 13, Issue

Biologics: Targets and Therapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers

Current issue
All volumes & issues
Most read articles
Most cited articles

New content alerts
RSS

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Cover image for Biologics: Targets and Therapy, Volume 13, 2019

Biologics: Targets and Therapy, Volume 13, Issue (2019)

Browse this journal

Current issue
List of issues
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Biologics: Targets and Therapy, Volume 13, Issue (2019)

See all volumes and issues

Vol 18, 2024 Vol 17, 2023 Vol 16, 2022 Vol 15, 2021 Vol 14, 2020 Volume 13, 2019 Vol 12, 2018 Vol 11, 2017 Vol 10, 2016 Vol 9, 2015 Vol 8, 2014 Vol 7, 2013 Vol 6, 2012 Vol 5, 2011 Vol 4, 2010 Vol 3, 2009 Vol 2, 2008 Vol 1, 2007

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Review Article

Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy

Michelle E Keyel & C Patrick Reynolds

Pages: 1-12

Published online: 11 Dec 2022

AbstractforSpotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy | Full Text | References | PDF (870.3 KB) | EPUB

402 Views
20 CrossRef citations
0Altmetric

Open Access

Original Research

Article

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience

Patrizia Alvisi, Serena Arrigo, Salvatore Cucchiara, Paolo Lionetti, Erasmo Miele, Claudio Romano, Alberto Ravelli, Daniela Knafelz, Stefano Martelossi, Graziella Guariso, Salvatore Accomando, Giovanna Zuin, Costantino De Giacomo, Lucio Balzani, Monia Gennari, Marina Aloi & On behalf of the SIGENP IBD Working Group

Pages: 13-21

Published online: 11 Dec 2022

AbstractforEfficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience | Full Text | References | PDF (572.3 KB) | EPUB

103 Views
6 CrossRef citations
0Altmetric

Open Access

Review

Review Article

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?

Angelo Viscido, Claudio Papi, Giovanni Latella & Giuseppe Frieri

Pages: 23-31

Published online: 11 Dec 2022

AbstractforHas infliximab influenced the course and prognosis of acute severe ulcerative colitis? | Full Text | References | PDF (285.3 KB) | EPUB

128 Views
4 CrossRef citations
0Altmetric

Open Access

Review Article

Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy

Esteban Cruz & Veysel Kayser

Pages: 33-51

Published online: 01 May 2019

AbstractforMonoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy | Full Text | References | PDF (2.7 MB) | EPUB

1102 Views
67 CrossRef citations
0Altmetric

Open Access

Review Article

Systematic review of immunomodulatory therapies for hidradenitis suppurativa

Shi Yu Derek Lim & Hazel H Oon

Pages: 53-78

Published online: 11 Dec 2022

AbstractforSystematic review of immunomodulatory therapies for hidradenitis suppurativa | Full Text | References | PDF (1,012 KB) | EPUB

317 Views
19 CrossRef citations
0Altmetric

Open Access

Case Report

Dupilumab side effect in a patient with atopic dermatitis: a case report study

Sakhar S Albader, Abdulmajeed A Alharbi, Rakan F Alenezi & Fahad M Alsaif

Pages: 79-82

Published online: 13 May 2019

AbstractforDupilumab side effect in a patient with atopic dermatitis: a case report study | Full Text | References | PDF (670.6 KB) | EPUB

399 Views
11 CrossRef citations
0Altmetric

Open Access

Case Report

Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau

LM Smirnova, E Yu Vertieva, O Yu Olisova & EM Anpilogova

Pages: 83-87

Published online: 20 May 2019

AbstractforOutcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau | Full Text | References | PDF (1,022.2 KB) | EPUB

87 Views
4 CrossRef citations
0Altmetric

Open Access

Review

Article

New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic

Marco Caminati, Diego Bagnasco, Rachele Vaia & Gianenrico Senna

Pages: 89-95

Published online: 11 Dec 2022

AbstractforNew horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic | Full Text | References | PDF (587.6 KB) | EPUB

126 Views
4 CrossRef citations
0Altmetric

Open Access

Case Report

Article

Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)

Farhad Salehzadeh, Yusef Mohammadikebar, Afsaneh Enteshary, Omid Ghanbarpour & Mehrdad Mirzarahimi

Pages: 97-99

Published online: 27 May 2019

AbstractforInfliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG) | Full Text | References | PDF (283.1 KB) | EPUB

92 Views
0 CrossRef citations
0Altmetric

Open Access

Original Research

Article

TRIP6 functions as a potential oncogene and facilitated proliferation and metastasis of gastric cancer

Lirong Zhu, Xiaodong Xu, Yijie Tang & Xiaochao Zhu

Pages: 101-110

Published online: 11 Jun 2019

AbstractforTRIP6 functions as a potential oncogene and facilitated proliferation and metastasis of gastric cancer | Full Text | References | PDF (2 MB) | EPUB

104 Views
3 CrossRef citations
0Altmetric

Open Access

Case Report

Recurrent ruptured abdominal aneurysms in polyarteritis nodosa successfully treated with infliximab

Butsabong Lerkvaleekul, Suporn Treepongkaruna, Nichanan Ruangwattanapaisarn, Tharintorn Treesit & Soamarat Vilaiyuk

Pages: 111-116

Published online: 14 Jun 2019

AbstractforRecurrent ruptured abdominal aneurysms in polyarteritis nodosa successfully treated with infliximab | Full Text | References | PDF (1.1 MB) | EPUB

82 Views
4 CrossRef citations
0Altmetric

Open Access

Original Research

Article

Antitumor and antibacterial properties of virally encoded cationic sequences

Jean-Hervé Colle, Bruno Périchon & Alphonse Garcia

Pages: 117-126

Published online: 25 Jun 2019

AbstractforAntitumor and antibacterial properties of virally encoded cationic sequences | Full Text | References | PDF (731.6 KB) | EPUB

93 Views
2 CrossRef citations
0Altmetric

Open Access

Review

Review Article

Therapeutic drug monitoring of biologics in psoriasis

MeiQi May Liau & Hazel H Oon

Pages: 127-132

Published online: 05 Jul 2019

AbstractforTherapeutic drug monitoring of biologics in psoriasis | Full Text | References | PDF (149.9 KB) | EPUB

242 Views
12 CrossRef citations
0Altmetric

Open Access

Article

Clinical utility of ramucirumab in non-small-cell lung cancer

Dipesh Uprety

Pages: 133-137

Published online: 22 Jul 2019

AbstractforClinical utility of ramucirumab in non-small-cell lung cancer | Full Text | References | PDF (218.8 KB) | EPUB

131 Views
4 CrossRef citations
0Altmetric

Open Access

Review Article

Remicade^® (infliximab): 20 years of contributions to science and medicine

Richard Melsheimer, Anja Geldhof, Isabel Apaolaza & Thomas Schaible

Pages: 139-178

Published online: 30 Jul 2019

AbstractforRemicade^® (infliximab): 20 years of contributions to science and medicine | Full Text | References | PDF (2.4 MB) | EPUB

1269 Views
36 CrossRef citations
0Altmetric

Open Access

Original Research

Article

Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats

Nur Samsu, Setyawati Soeharto, Muhaimin Rifai & Achmad Rudijanto

Pages: 179-190

Published online: 30 Aug 2019

AbstractforRosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats | Full Text | References | PDF (2.6 MB) | EPUB

165 Views
2 CrossRef citations
0Altmetric

Open Access

Article

Efficacy And Safety Of Adalimumab Biosimilar (Exemptia) In Moderate-To-Severe Steroid-Refractory Ulcerative Colitis Patients: Real-Life Outcomes In Resource-Constrained Setting At 24-Weeks Follow-Up

Alok Chandra, Ravi Kanth & Sandeep Thareja

Pages: 191-200

Published online: 25 Nov 2019

AbstractforEfficacy And Safety Of Adalimumab Biosimilar (Exemptia) In Moderate-To-Severe Steroid-Refractory Ulcerative Colitis Patients: Real-Life Outcomes In Resource-Constrained Setting At 24-Weeks Follow-Up | Full Text | References | PDF (946.2 KB) | EPUB

121 Views
2 CrossRef citations
0Altmetric

Open Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

LncRNA GAS5 Modulates the Progression of Glioma Through Repressing miR-135b-5p and Upregulating APC

Jidong Zhang et al.

Article | Published online: 23 May 2024

Open Access

Gene Expression, Morphology, and Electrophysiology During the Dynamic Development of Human Induced Pluripotent Stem Cell-Derived Atrial- and Ventricular-Like Cardiomyocytes

Yafei Zhou et al.

Article | Published online: 9 May 2024

Open Access

Successful Fistula Closure After Treatment with Colostomy and Infliximab in a Patient with Ulcerative Colitis Complicated by Rectovaginal Fistula

Sota Katsube et al.

Case Report | Published online: 5 May 2024

Open Access

TNFSF13B rs9514828 C>T Polymorphism is Associated with Incidence of Atherosclerosis and Therapeutic Outcomes in Patients with Systemic Lupus Erythematosus

Desi Reski Fajar et al.

Article | Published online: 2 May 2024

Open Access

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Biologics: Targets and Therapy (Vol.13, Iss., 2019)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?